Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Borer

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of the American Heart Association|February 14, 2016
Effect of Visit-to-Visit Variation of Heart Rate and Systolic Blood Pressure on Outcomes in Chronic Systolic Heart Failure: Results From the Systolic Heart Failure Treatment With the If Inhibitor Ivabradine Trial (SHIFT) TrialMichael Böhm, Michele Robertson, Jeffrey Borer, et al.
European Journal of Heart Failure|April 24, 2023
Time to benefit of heart rate reduction with ivabradine in patients with heart failure and reduced ejection fractionMichael Böhm, Amr Abdin, Jonathan Slawik, et al.
The Canadian Journal of Cardiology|June 23, 2015
Pharmacologic Options for the Management of Systolic Heart Failure: Examining Underlying MechanismsG B John Mancini, Jonathan G Howlett, Jeffrey Borer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 12, 2012
Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT studyMichael Böhm, Jeffrey Borer, Ian Ford, et al.
The American Journal of Gastroenterology|March 15, 2018
Acute pancreatitis with long-term celecoxib vs. ibuprofen or naproxen: data from the PRECISION trialNeville D Yeomans, David Y Graham, Qiuqing Wang, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of the American Heart Association|February 14, 2016
Effect of Visit-to-Visit Variation of Heart Rate and Systolic Blood Pressure on Outcomes in Chronic Systolic Heart Failure: Results From the Systolic Heart Failure Treatment With the If Inhibitor Ivabradine Trial (SHIFT) TrialMichael Böhm, Michele Robertson, Jeffrey Borer, et al.
European Journal of Heart Failure|April 24, 2023
Time to benefit of heart rate reduction with ivabradine in patients with heart failure and reduced ejection fractionMichael Böhm, Amr Abdin, Jonathan Slawik, et al.
The Canadian Journal of Cardiology|June 23, 2015
Pharmacologic Options for the Management of Systolic Heart Failure: Examining Underlying MechanismsG B John Mancini, Jonathan G Howlett, Jeffrey Borer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 12, 2012
Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT studyMichael Böhm, Jeffrey Borer, Ian Ford, et al.
The American Journal of Gastroenterology|March 15, 2018
Acute pancreatitis with long-term celecoxib vs. ibuprofen or naproxen: data from the PRECISION trialNeville D Yeomans, David Y Graham, Qiuqing Wang, et al.
Pageof 2